KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) EPS (Basic) (2016 - 2025)

Pfizer (PFE) has disclosed EPS (Basic) for 17 consecutive years, with -$0.28 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 500.0% to -$0.28 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.37, a 3.52% decrease, with the full-year FY2025 number at $1.37, down 3.52% from a year prior.
  • EPS (Basic) was -$0.28 for Q4 2025 at Pfizer, down from $0.62 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.76 in Q3 2022 to a low of -$0.59 in Q4 2023.
  • A 5-year average of $0.62 and a median of $0.58 in 2024 define the central range for EPS (Basic).
  • Biggest YoY gain for EPS (Basic) was 5000.0% in 2025; the steepest drop was 500.0% in 2025.
  • Pfizer's EPS (Basic) stood at $1.45 in 2021, then rose by 6.21% to $1.54 in 2022, then tumbled by 138.31% to -$0.59 in 2023, then soared by 111.86% to $0.07 in 2024, then plummeted by 500.0% to -$0.28 in 2025.
  • Per Business Quant, the three most recent readings for PFE's EPS (Basic) are -$0.28 (Q4 2025), $0.62 (Q3 2025), and $0.51 (Q2 2025).